Observational Study
Copyright ©The Author(s) 2022.
World J Gastroenterol. Aug 21, 2022; 28(31): 4417-4430
Published online Aug 21, 2022. doi: 10.3748/wjg.v28.i31.4417
Figure 3
Figure 3 Outcomes of autoimmune liver disease patients with acute decompensated cirrhosis and acute-on-chronic liver failure. A: Liver transplantation (LT)-free mortality in patients with cirrhosis and acute decompensation; B: LT-free mortality in patients with acute-on-chronic liver failure. LT: Liver transplantation; PBC: Primary biliary cirrhosis; AIH: Autoimmune hepatitis; PBC/AIH: Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome; AD: Acute decompensation; ACLF: Acute-on-chronic liver failure.

  • Citation: Shen ZX, Wu DD, Xia J, Wang XB, Zheng X, Huang Y, Li BL, Meng ZJ, Gao YH, Qian ZP, Liu F, Lu XB, Shang J, Yan HD, Zheng YB, Gu WY, Zhang Y, Wei JY, Tan WT, Hou YX, Zhang Q, Xiong Y, Zou CC, Chen J, Huang ZB, Jiang XH, Luo S, Chen YY, Gao N, Liu CY, Yuan W, Mei X, Li J, Li T, Zhou XY, Deng GH, Chen JJ, Ma X, Li H. Prevalence and clinical characteristics of autoimmune liver disease in hospitalized patients with cirrhosis and acute decompensation in China. World J Gastroenterol 2022; 28(31): 4417-4430
  • URL: https://www.wjgnet.com/1007-9327/full/v28/i31/4417.htm
  • DOI: https://dx.doi.org/10.3748/wjg.v28.i31.4417